Inhibition of Vesicular Glutamate Transporters (VGLUTs) with Chicago Sky Blue 6B Before Focal Cerebral Ischemia Offers Neuroprotection
出版年份 2023 全文链接
标题
Inhibition of Vesicular Glutamate Transporters (VGLUTs) with Chicago Sky Blue 6B Before Focal Cerebral Ischemia Offers Neuroprotection
作者
关键词
-
出版物
MOLECULAR NEUROBIOLOGY
Volume 60, Issue 6, Pages 3130-3146
出版商
Springer Science and Business Media LLC
发表日期
2023-02-20
DOI
10.1007/s12035-023-03259-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of optimal reference genes for gene expression studies in a focal cerebral ischaemia model—Spatiotemporal effects
- (2022) Bartosz Pomierny et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Machine Learning algorithm unveils glutamatergic alterations in the post-mortem schizophrenia brain
- (2022) Arianna De Rosa et al. npj Schizophrenia
- Vesicular Glutamate Transporters (SLCA17 A6, 7, 8) Control Synaptic Phosphate Levels
- (2021) Cyril Cheret et al. Cell Reports
- Post-stroke Neurogenesis: Friend or Foe?
- (2021) María Isabel Cuartero et al. Frontiers in Cell and Developmental Biology
- The Slow-Releasing and Mitochondria-Targeted Hydrogen Sulfide (H2S) Delivery Molecule AP39 Induces Brain Tolerance to Ischemia
- (2021) Bartosz Pomierny et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Chicago sky blue 6B (CSB6B), an allosteric inhibitor of macrophage migration inhibitory factor (MIF), suppresses osteoclastogenesis and promotes osteogenesis through the inhibition of the NF-κB signaling pathway
- (2021) Kangtao Jin et al. BIOCHEMICAL PHARMACOLOGY
- Increase in Glutamatergic Terminals in the Striatum Following Dopamine Depletion in a Rat Model of Parkinson’s Disease
- (2019) Xuefeng Zheng et al. NEUROCHEMICAL RESEARCH
- Tau pathology and neurochemical changes associated with memory dysfunction in an optimised murine model of global cerebral ischaemia - A potential model for vascular dementia?
- (2018) Sabah Khan et al. NEUROCHEMISTRY INTERNATIONAL
- Global Burden of Stroke
- (2018) Mira Katan et al. SEMINARS IN NEUROLOGY
- Electroacupuncture Alleviates Motor Symptoms and Up-Regulates Vesicular Glutamatergic Transporter 1 Expression in the Subthalamic Nucleus in a Unilateral 6-Hydroxydopamine-Lesioned Hemi-Parkinsonian Rat Model
- (2018) Yanyan Wang et al. Neuroscience Bulletin
- Glutamate transporters in brain ischemia: to modulate or not?
- (2014) Weronika Krzyżanowska et al. ACTA PHARMACOLOGICA SINICA
- The antinociceptive effects of intracerebroventricular administration of Chicago sky blue 6B, a vesicular glutamate transporter inhibitor
- (2013) Gang Yu et al. BEHAVIOURAL PHARMACOLOGY
- Age and meloxicam modify the response of the glutamate vesicular transporters (VGLUTs) after transient global cerebral ischemia in the rat brain
- (2013) Irene L. Llorente et al. BRAIN RESEARCH BULLETIN
- Chicago sky blue 6B, a vesicular glutamate transporters inhibitor, attenuates methamphetamine-induced hyperactivity and behavioral sensitization in mice
- (2012) Zongsheng He et al. BEHAVIOURAL BRAIN RESEARCH
- From glutamate co-release to vesicular synergy: vesicular glutamate transporters
- (2011) Salah El Mestikawy et al. NATURE REVIEWS NEUROSCIENCE
- Molecular and cellular mechanisms of excitotoxic neuronal death
- (2010) Yan Wang et al. APOPTOSIS
- Increased vesicular glutamate transporter expression causes excitotoxic neurodegeneration
- (2010) Richard W. Daniels et al. NEUROBIOLOGY OF DISEASE
- Enhanced neurogenesis and cell migration following focal ischemia and peripheral stimulation in mice
- (2008) Wen-Lei Li et al. Developmental Neurobiology
- Plasticity and repair in the post-ischemic brain
- (2008) Massimiliano Di Filippo et al. NEUROPHARMACOLOGY
- Loss of VGLUT1 and VGLUT2 in the prefrontal cortex is correlated with cognitive decline in Alzheimer disease
- (2007) Alireza Kashani et al. NEUROBIOLOGY OF AGING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started